These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 316848)

  • 1. Influence of bupropion HCl (Wellbatrin), a novel antidepressant, on plasma levels of prolactin and growth hormone in man and rat.
    Stern WC; Rogers J; Fang V; Meltzer H
    Life Sci; 1979 Nov; 25(20):1717-24. PubMed ID: 316848
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of bupropion to affect prolactin or growth hormone in man.
    Whiteman PD; Peck AW; Fowle AS; Smith PR
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):209-10. PubMed ID: 6406460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion fails to affect plasma prolactin and growth hormone in normal subjects.
    Whiteman PD; Peck AW; Fowle AS; Smith P
    Br J Clin Pharmacol; 1982 May; 13(5):743-5. PubMed ID: 6805494
    [No Abstract]   [Full Text] [Related]  

  • 4. The lack of effect of bupropion HCL (Wellbatrin) on the secretion of growth hormone and prolactin in humans.
    Laakmann G; Hoffmann N; Hofschuster E
    Life Sci; 1982 May; 30(20):1725-32. PubMed ID: 6124859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus properties of antidepressants in the rat.
    Jones CN; Howard JL; McBennett ST
    Psychopharmacology (Berl); 1980 Feb; 67(2):111-8. PubMed ID: 6768086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels.
    Meltzer HY; Simonovic M; Sturgeon RD; Fang VS
    Acta Psychiatr Scand Suppl; 1981; 290():100-21. PubMed ID: 6971560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of bupropion, a new antidepressant drug, and diazepam, and their interaction in man.
    Hamilton MJ; Bush M; Smith P; Peck AW
    Br J Clin Pharmacol; 1982 Dec; 14(6):791-7. PubMed ID: 6817770
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of bupropion on haloperidol and morphine catalepsy in the rat.
    Kop PB; Muley MP; Balsara JJ
    Indian J Physiol Pharmacol; 1990 Jul; 34(3):218-9. PubMed ID: 2126779
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone response to 5-HTP: a reply.
    van Praag HM; Westenberg HG; Thijssen JH; de Jong JT
    Psychiatry Res; 1984 Jan; 11(1):79. PubMed ID: 6608744
    [No Abstract]   [Full Text] [Related]  

  • 12. The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings].
    Canning H; Goff D; Leach MJ; Miller AA; Tateson JE; Wheatley PL
    Br J Pharmacol; 1979 May; 66(1):104P-105P. PubMed ID: 454899
    [No Abstract]   [Full Text] [Related]  

  • 13. Animal models used in prediction of antidepressant effects in man.
    Cooper BR; Howard JL; Soroko FE
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):63-6. PubMed ID: 6406466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptual changes with bupropion, a novel antidepressant.
    Becker RE; Dufresne RL
    Am J Psychiatry; 1982 Sep; 139(9):1200-1. PubMed ID: 6810715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacologic basis for therapeutic interest in bupropion.
    Soroko FE; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of bupropion to affect tyramine response in man.
    Fowle AS; Peck AW; Rogers HJ; Spector RG
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):211. PubMed ID: 6406461
    [No Abstract]   [Full Text] [Related]  

  • 18. Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion.
    Laakmann G; Schüle C; Baghai T; Waldvogel E; Bidlingmaier M; Strasburger C
    J Clin Psychopharmacol; 2000 Feb; 20(1):101-3. PubMed ID: 10653218
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of bupropion's mechanism of antidepressant activity.
    Ferris RM; Cooper BR; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.